Ipamorelin 10mg

Ipamorelin 10 mg — Research Peptide

Ipamorelin is a synthetic pentapeptide developed by Novo Nordisk and, since its first description (Raun et al., 1998), considered the most selective growth hormone secretagogue (GHS) among ghrelin mimetics. Unlike GHRP-2 or GHRP-6, it does not elevate cortisol or prolactin.

Product Details

• Net weight: 10 mg (lyophilised)
• Purity: ≥98.9% (HPLC-verified)
• Identity confirmed by LC-MS
• Batch-specific COA included

Receptor Target

• Ghrelin Receptor (GHSR-1a) — selective agonist
• No significant effect on cortisol, prolactin, ACTH, FSH, LH

For research purposes only. Not intended for human use.

Reconstitution: Example Calculation

For a working concentration of 10 mg/ml, reconstitute the 10 mg vial with 1 ml of sterile bacteriostatic water (BAC water). Inject the water slowly along the inside wall of the vial and swirl gently rather than shaking.

Frequently Asked Questions

What sets Ipamorelin apart from other ghrelin mimetics?
Unlike GHRP-2 or GHRP-6, Ipamorelin does not elevate cortisol or prolactin levels according to Raun et al. (1998), making it a more selective research tool.

Is Ipamorelin often studied in combination with other peptides?
In the research literature, Ipamorelin is frequently studied alongside GHRH analogues such as CJC-1295 to capture synergistic effects on GH release.

Quality Assurance

Every production batch goes through independent dual verification: HPLC analysis to determine purity, and LC-MS analysis to unambiguously confirm molecular mass and correct peptide sequence. Only after passing both checks is a batch released, shipped with a batch-specific Certificate of Analysis (COA).